I totally agree that continued trials will be beneficial in maximizing the potential benefit of LL for covid & possibly carrying over to other indications. FDA could request something for that very reason & CYDY might comply for the same reason. But it will not be for fear of being left behind. Way too much good news, today. Meantime, LL reduces mortality by 24% & keeps hospitals from being overwhelmed by reducing hospital stay & not requiring iv. We are now in the deep end with the big boys & girls. So it's time to learn to swim or grab your water wings. Enjoy the moment. The cold slap in the face is not coming THIS time. GLTU.